Principles of the combination of chemically complementary grades of Eudragit® copolymers in peroral, matrix, and reservoir types of solid dosage forms with modified release [tablets, microspheres, (micro)pellets] and their manufacturing technology (including film coatings) are considered. Modified drug release is achieved due to the interaction between reactive groups of copolymer pairs, which controls the drug release process both inside matrices and within multilayers or combined coatings. Analysis of these processes has key significance for developing (meth)acrylate polycomplexes, which could be synthesized in both aqueous and organic media, as new classes of drug carriers for constructing modern peroral drug delivery systems.
Similar content being viewed by others
References
V. A. Kemenova, R. I. Mustafin, K. V. Alekseev, et al., Farmatsiya, 60(1), 67 – 72 (1991).
A. B. Zezin and V. B. Rogacheva, Usp. Khim. Fiz. Polim., 3 – 30 (1973).
V. A. Kabanov, Usp. Khim., 74(1), 5 – 23 (2005).
E. Tsuchida, J. Macromol. Sci., Part A: Pure Appl. Chem., 31, 1 – 15 (1994).
A. F. Thunemann, M. Muller, H. Dautzenberg, et al., Adv. Polym. Sci., 166, 113 – 171 (2004).
V. V. Khutoryanskiy, in: Hydrogen-bonded interpolymer complexes. Formation, structure and applications, V. V. Khutoryanskiy and G. Staikos (eds.), World Scientific Publishing Co., Pte. Ltd., Singapore (2009), pp. 235 – 258.
V. V. Khutoryanskiy, Int. J. Pharm., 334, 15 – 26 (2007).
M. S. Hartig, R. R. Greene, M. M. Dikov, et al., Pharm. Res., 24(12), 2353 – 2369 (2007).
S. Lankalapalli and V. R. M. Kolapalli, Indian J. Pharm. Sci., 71, 481 – 487 (2009).
M. Dittgen, M. Durrani, and K. Lehmann, STP Pharma Sci., 7, 403 – 437 (1997).
Degussa / Pharma Polymers. Eudragit® Application Guidelines (2007).
B. Skalsky and H.-U. Petereit, in: Aqueous polymeric coatings for pharmaceutical dosage forms, J. W. McGinity and L. A. Felton (eds.), Informa Healthcare, New York (2008), pp. 237 – 279.
F. Siepmann, J. Siepmann, M. Walther, et al., J. Controlled Release, 125, 1 – 15 (2008).
D. Gallardo, B. Skalsky, and P. Kleinebudde, Pharm. Dev. Technol., 13(5), 413 – 423 (2008).
C. G. Cameron and J. W. McGinity, Drug. Dev. Ind. Pharm., 13(8), 1409 – 1427 (1987).
S.-Y. Lin, C.-M. Liao, G.-H. Hsuie, and R.-C. Liang, Thermochim. Acta, 245, 153 – 166 (1995).
A. Ceballos, M. Cirri, F. Maestrelli, et al., IL Farmaco, 60(11 – 12), 913 – 918 (2005).
H. O. Ammar and R. M. Khalil, Drug. Dev. Ind. Pharm., 23(11), 1043 – 1054 (1997).
M. S. Kislalioglu, M. A. Khan, C. Blount, et al., J. Pharm. Sci., 80(8), 799 – 804 (1991).
A. A. Karnachi and M. A. Khan, Int. J. Pharm., 131, 9 – 17 (1996).
A. M. Rabasco-Alvarez, M. A. Holgado-Villafuerte, M. Fernandez-Arevalo, and J. M. Gines-Dorado, Eur. J. Pharm. Biopharm., 37(3), 147 – 153 (1991).
M. Fernandez-Arevalo, M. A. Holgado-Villafuerte, J. M. Gines-Dorado, and A. M. Rabasco-Alvarez, Int. J. Pharm., 95, 117 – 125 (1993).
I. Ozguney (Sarigullu), G. Ertan, and T. Guneri, IL Farmaco, 59, 549 – 555 (2004).
B. Skalsky, K. Nollenberger, and A. Gryczke, in: Transact. 36 th Annual Meeting & Exposition of the CRS, Copenhagen (2009).
M. L. Lorenzo-Lamoza, M. Cuna, J. L. Vila-Jato, et al., J. Microencapsulation, 14(5), 607 – 616 (1997).
M. Kilicarslan and T. Baykara, J. Microencapsulation, 21(2), 175 – 189 (2004).
J. Ly and X. Y. Wu, Pharm. Dev. Technol., 4(2), 257 – 267 (1999).
K. Vasilevska, Z. Djuric, M. Jovanovic, and A. Simov, Drug. Dev. Ind. Pharm., 18(15), 1649 – 1661 (1992).
Z.-Z. Piao, M.-K. Lee, and B.-J. Lee, Int. J. Pharm., 350, 205 – 211 (2008).
V. D. Kadam and S. G. Gattani, Pharm. Dev. Technol., 15(1), 64 – 70 (2010).
A. Akhgari, F. Sadeghi, and H. A. Garekani, Int. J. Pharm., 320, 137 – 142 (2006).
M. Katsuma, S. Watanabe, S. Takemura, et al., J. Pharm. Sci., 93(5), 1287 – 1299 (2004).
C. B. Wu and J. W. McGinity, Pharm. Dev. Technol., 8(1), 103 – 110 (2003).
H. Ichikawa, Y. Fukumori, and M. C. Adeyeye, Int. J. Pharm., 156, 39 – 48 (1997).
M. C. Adeyeye, E. Mwangi, B. Katondo, et al., J. Microencapsulation, 22(4), 333 – 342 (2005).
T.-W. Kim, H. San, and B.-J. Lee, Chem. Pharm. Bull., 55(7), 975 – 979 (2007).
V. K. Gupta, T. E. Beckert, and J. C. Price, Int. J. Pharm., 213, 83 – 91 (2001).
V. K. Gupta, M. W. Assumus, T. E. Beckert, and J. C. Price, Int. J. Pharm., 213, 93 – 102 (2001).
V. K. Gupta, T. E. Beckert, N. J. Deusch, et al., Drug. Dev. Ind. Pharm., 28(2), 207 – 215 (2002).
M. W. Rudolph, S. Klein, T. E. Beckert, et al., Eur. J. Pharm. Biopharm., 51, 183 – 190 (2001).
D. Sauer, W. Zheng, L. B. Coots, and J. W. McGinity, Eur. J. Pharm. Biopharm., 67, 464 – 475 (2007).
D. Sauer, A. B. Watts, L. B. Coots, et al., Int. J. Pharm., 367, 20 – 28 (2009).
D. Sauer and J. W. McGinity, Pharm. Dev. Technol., 14(6), 632 – 641 (2009).
R. I. Mustafin and T. V. Kabanova, Khim.-farm. Zh., 38(11), 39 – 41 (2004).
R. I. Mustafin and T. V. Kabanova, Khim.-farm. Zh., 39(2), 34 – 38 (2005).
R. I. Moustafine, T. V. Kabanova, V. A. Kemenova, and G. Van den Mooter, J. Controlled Release, 103, 191 – 198 (2005).
R. I. Moustafine, in: Proc. 5 th World Meeting (APV / APGI) on Pharm. Biopharm. & Pharm. Technol., Geneva (2006), Abstr. 16.
R. I. Moustafine, I. M. Zaharov, and V. A. Kemenova, Eur. J. Pharm. Biopharm., 63(1), 26 – 36 (2006).
R. I. Moustafine and O. L. Bobyleva, in: Proc. 5 th World Meeting (APV / APGI) on Pharm. Biopharm. & Pharm. Technol., Geneva (2006), Abstr. 20.
R. I. Moustafine and O. L. Bobyleva, J. Controlled Release, 116(2), e35-e36 (2006).
R. I. Mustafin, O. L. Bobyleva, V. L. Bobyleva, et al., Khim.-farm. Zh., 44(6), 33 – 37 (2010).
R. I. Mustafin, V. L. Bobyleva, and V. A. Kemenova, Khim.-farm. Zh., 44(7), 44 – 48 (2010).
R. I. Moustafine, V. L. Bobyleva, A. V. Buhovets, et al., J. Pharm. Sci., 100(3), 874 – 885 (2011).
R. I. Mustafin, A. B. Bilan, A. V. Bukhovets, et al., Khim.-farm. Zh., 45(2), 53 – 56 (2011).
W. M. Obeidat, A. H. Abu Znait, and A. A. Sallam, Drug. Dev. Ind. Pharm., 34(6), 650 – 660 (2008).
W. M. Obeidta, A. H. Abu Znait, and A. A. Sallam, AAPS PharmSciTech, 11(1), 54 – 63 (2010).
F. Cilurzo, P. Minghetti, A. Casiraghi, and L. Montanari, J. Appl. Polym. Sci., 76, 1662 – 1668 (2000).
A. R. Menjoge and M. G. Kulkarni, Int. J. Pharm., 343, 106 – 121 (2007).
S.-Y. Lin, H.-L. Yu, and M.-J. Li, Polymer, 40, 3589 – 3593 (1999).
Y. Zhang, L. Hu, Y. Min, et al., Eur. Polym. J., 42(11), 2959 – 2967 (2006).
D. Gallardo, M. Assmus, P. Kleinebudde, and B. Skalsky, AAPS Annual Meeting, San Diego, CA (2007), Abstr. 50.
D. Gallardo, M. Assmus, P. Kleinebudde, and B. Skalsky, AAPS Annual Meeting, San Diego, CA (2007), Abstr. 51.
D. Gallardo, M. Assmus, P. Kleinebudde, and B. Skalsky, in: Proc. 6 th World Meeting (APV / APGI) on Pharm. Biopharm. & Pharm. Technol., Barcelona (2008), Abstr. 45.
F. Gabor, C. Fillafer, L. Neutsch, et al., Improving Oral Delivery, in: Handbook of Experimental Pharmacology, M. Schafer-Korting (ed.), Springer-Verlag, Berlin, Heidelberg (2010), pp. 365 – 399.
Acknowledgments
We thank Dr. Chem. Sci. V. A. Kemenova for discussion of certain key aspects of the work and graduate and undergraduate students of the Department of Pharmaceutical Chemistry from courses in analytical and toxicological chemistry of KSMU who participated in carrying out several of the studies cited above.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 45, No. 5, pp. 28 – 39, May, 2011.
Rights and permissions
About this article
Cite this article
Mustafin, R.I. Interpolymer combinations of chemically complementary grades of Eudragit copolymers: a new direction in the design of peroral solid dosage forms of drug delivery systems with controlled release (review). Pharm Chem J 45, 285–295 (2011). https://doi.org/10.1007/s11094-011-0618-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-011-0618-7